UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009299
Receipt number R000010907
Scientific Title Effect of frequency-modulated electromagnetic therapy for increasing the lower extremity deep-vein blood flow, and improving edema: a randomized, placebo controlled trial
Date of disclosure of the study information 2012/11/09
Last modified on 2020/05/25 16:41:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of frequency-modulated electromagnetic therapy for increasing the lower extremity deep-vein blood flow, and improving edema: a randomized, placebo controlled trial

Acronym

Effect of frequency-modulated electromagnetic therapy on deep-vein blood flow and edema

Scientific Title

Effect of frequency-modulated electromagnetic therapy for increasing the lower extremity deep-vein blood flow, and improving edema: a randomized, placebo controlled trial

Scientific Title:Acronym

Effect of frequency-modulated electromagnetic therapy on deep-vein blood flow and edema

Region

Japan


Condition

Condition

edema, peripheral vascular disease

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The current study is to: 1) compare the before-after change of the lower extremity deep-vein blood flow, muscle hardness, and leg volume; and 2) compare the changes of aforementioned parameters among groups with the intervention of an electromagnetic therapy machine, a placebo machine, or without intervention.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Difference of the speed of the leg deep-vein blood flow
Change rate of the speed of the leg deep-vein blood flow

Key secondary outcomes

Difference of the gastrocnemius muscle hardness
Difference of the calf circumference
Difference of the calf volume
Difference of subjective estimative index with questionnaire


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

frequency-modulated electromagnetic therapy (electromagnetic therapy) -> an over 24h washout period (WO) -> dummy machine (placebo) -> WO -> without intervention

Interventions/Control_2

electromagnetic therapy -> WO -> without intervention -> WO -> placebo

Interventions/Control_3

placebo -> WO -> electromagnetic therapy -> WO -> without intervention

Interventions/Control_4

placebo -> WO -> without intervention -> WO -> electromagnetic therapy

Interventions/Control_5

without intervention-> WO -> electromagnetic therapy -> WO -> placebo

Interventions/Control_6

without intervention -> WO -> placebo -> WO -> electromagnetic therapy

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Outpatients of Seisen Clinic Orthopedics in Sizuoka,
Males and females aged over 18 years,
Without history of venous thrombosis,
Without history of lower extremity surgery,
Without history of diabetes, cardiac disease or respiratory disease,
Without communication problem.

Key exclusion criteria

Patients underwent injury treatment,
Patients with lower extremity deisease or underwent leg rehabilitates,
Patients with nerve disease,
Patients who was judged ineligible to be recruited by the principal investigator.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keika HOSHI

Organization

Kitasato University, School of Medicine

Division name

Department of Preventive Medicine

Zip code


Address

1-15-1 Kitasato, Minami-ku, Sagamihara 252-0374 Kanagawa, Japan

TEL

0427788111

Email

kcrcinfo@med.kitasato-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasutoshi SAKAMOTO

Organization

Kitasato University, School of Medicine

Division name

Kitasato Clinical Research Center

Zip code


Address

1-15-1 Kitasato, Minami-ku, Sagamihara 252-0374 Kanagawa, Japan

TEL

+81-(0)42-777-6308

Homepage URL


Email

kcrcinfo@med.kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato Clinical Research Center

Institute

Department

Personal name



Funding Source

Organization

NIKKEN Inc

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Seisen Clinic Orthopedics

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

清泉クリニック整形外科(静岡) Seisen Clinic Orthopedics


Other administrative information

Date of disclosure of the study information

2012 Year 11 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 09 Month 12 Day

Date of IRB

2012 Year 09 Month 12 Day

Anticipated trial start date

2012 Year 11 Month 07 Day

Last follow-up date

2013 Year 01 Month 31 Day

Date of closure to data entry

2013 Year 03 Month 31 Day

Date trial data considered complete

2013 Year 03 Month 31 Day

Date analysis concluded

2016 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 11 Month 09 Day

Last modified on

2020 Year 05 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010907


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name